PREVENTION OF RECURRENT ATRIAL FIBRILLATION WITH ANGIOTENSIN-CONVERTING ENZYME INHIBITORS OR ANGIOTENSIN RECEPTOR BLOCKERS: A META-ANALYSIS OF RANDOMIZED TRIALS

被引:0
|
作者
Bhuriya, Rohit [1 ]
Bedi, Updesh [1 ]
Bahekar, Amol [1 ]
Molnar, Janos [1 ]
Singh, Mukesh [1 ]
Patel, Pawan [1 ]
Singh, Param Puneet [1 ]
Khosla, Sandeep [1 ]
Arora, Rohit [1 ]
机构
[1] Chicago Med Sch, N Chicago, IL USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1081-153
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers on insulin sensitivity in hypertensive patients: A meta-analysis of randomized controlled trials
    Yao, Jia
    Fan, Simin
    Shi, Xiaoyan
    Gong, Xiayu
    Zhao, Jia
    Fan, Guanjie
    [J]. PLOS ONE, 2021, 16 (07):
  • [22] Dose of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Outcomes in Heart Failure: A Meta-Analysis
    Khan, Muhammad Shahzeb
    Fonarow, Gregg C.
    Ahmed, Ali
    Greene, Stephen J.
    Vaduganathan, Muthiah
    Khan, Hassan
    Marti, Catherine
    Gheorghiade, Mihai
    Butler, Javed
    [J]. CIRCULATION-HEART FAILURE, 2017, 10 (08)
  • [23] Role of angiotensin-converting enzyme inhibitors in the prevention of atrial fibrillation
    Finkielstein, D
    Schweitzer, P
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (06): : 734 - 736
  • [24] The effect of angiotensin system inhibitors (angiotensin-converting enzyme inhibitors or angiotensin receptor blockers) on cancer recurrence and survival: a meta-analysis
    Song, Taejong
    Choi, Chel Hun
    Kim, Mi Kyoung
    Kim, Mi-La
    Yun, Bo Seong
    Seong, Seok Ju
    [J]. EUROPEAN JOURNAL OF CANCER PREVENTION, 2017, 26 (01) : 78 - 85
  • [25] Anti-inflammatory effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: potential benefits for the prevention of atrial fibrillation
    Liu, Tong
    Li, Guangping
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 (19) : 2370 - 2371
  • [26] Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers and Diabetes: A Meta-Analysis of Placebo-Controlled Clinical Trials
    Tocci, Giuliano
    Paneni, Francesco
    Palano, Francesca
    Sciarretta, Sebastiano
    Ferrucci, Andrea
    Kurtz, Theodore
    Mancia, Giuseppe
    Volpe, Massimo
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2011, 24 (05) : 582 - 590
  • [27] Reviewing the future of renin-angiotensin system blockade: The role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the prevention of atrial fibrillation
    Ducharme, Anique
    Schiffrin, Ernesto L.
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2010, 26 : 21E - 23E
  • [28] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in atherosclerosis
    Lonn E.
    [J]. Current Atherosclerosis Reports, 2002, 4 (5) : 363 - 372
  • [29] Role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cryoballoon ablation outcomes for paroxysmal atrial fibrillation
    Al-Seykal, Ibragim
    Bose, Abhishek
    Chevli, Parag A.
    Hashmath, Zeba
    Sharma, Nitish
    Mishra, Ajay K.
    Laidlaw, Douglas
    [J]. WORLD JOURNAL OF CARDIOLOGY, 2022, 14 (10): : 537 - 545
  • [30] IMPACT OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS, ANGIOTENSIN RECEPTOR BLOCKERS AND STATINS IN RHYTHM CONTROL STRATEGY OF ATRIAL FIBRILLATION
    Providencia, R.
    Botelho, A.
    Silva, J.
    Seca, L.
    Gomes, P. L.
    Barra, S.
    Quintal, N.
    Nascimento, J.
    Leitao-Marques, A. M.
    [J]. JOURNAL OF HYPERTENSION, 2010, 28 : E57 - E57